1A. Roessner,J. Vassallo,E. Vollmer,G. Zwadlo,C. Sorg,E. Grundmann. Biological characterization of human bone tumors[J] 1987,Journal of Cancer Research and Clinical Oncology(6):559～562
3Balke M, Schremper L, Gebert C, et al. Giant cell tumor of bone: treat- ment and outcome of 214 cases [J]. J Cancer Res Clin Oncol, 2008, 134(9): 969-978.
4Jaffe H L, Lichtcnstein L. Benign Chondroblastoma of Bone: A Rein- terpretation of the So-Called Calcifying or Chondromatous Giant Cell Tumor[J]. Am J Pathol, t942, 18(6): 969-991.
5Clark I M, Parker A E. Metalloproteinases: their role in arthritis and potential as therapeutic targets [J]. Expert Opin Ther Targets,2003,7 (1):19-34.
6D'Ortho M P, Will H, Atkinson S, et al. Membrane-type matrix met- alloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases [J]. Eur J Biochem, 1997,250(3):751-757.
7Yu A E, Hewitt R E, Kleiner D E, et al. Molecular regulation of cel- lular invasion--role of gelatinase A and TIMP-2[J]. Biochem Cell Biol, 1996, 74(6): 823-831.
8Ohtani H, Motohashi H, Sato H, et al. Dual over-expression pattern of membrane-type metalloproteinase-1 in cancer and stromal cells in hu- man gastrointestinal carcinoma revealed by in situ hybridization and immunoelectron microscopy[J]. Int J Cancer, 1996, 68(5): 565-570.
9Takahashi C, Sheng Z, Horan T P, et al. Regulation of matrix metal- loproteinase-9 and inhibition of tumor invasion by the membrane-an- chored glycoprotein RECK [J]. Proc Natl Acad Sci U S A, 1998, 95 (22): 13221-13226.
10Steck P A, Pershouse M A, Jasser S A, et al. Identification of a candi- date turnout suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers [J]. Nat Genet,1997,15 (4): 356-362.
